FDA Safety Alert: Benicar May Cause Severe Intestinal Damage
The FDA issued a safety alert in July 2013 for the blood pressure drug Benicar (olmesartan medoxomil) due to severe gastrointestinal side effects reported by users. These painful side effects include sprue-like enteropathy – a condition with symptoms similar to Celiac disease – and villous atrophy, a condition which destroys the ability of the small intestine to absorb nutrients. Both of these conditions can cause severe side effects including chronic diarrhea, substantial weight loss and malnutrition.
The FDA has ordered the manufacturer to include warnings of these side effects on the drug’s packaging, and the authors of the FDA study called these side effects “life-threatening.”
“The FDA’s evaluation found clear evidence of an association between olmesartan and sprue-like enteropathy. If patients taking olmesartan develop these symptoms and no other cause is found, the drug should be discontinued and therapy with another antihypertensive started.”
If you or a loved one has suffered gastrointestinal injuries as a result of taking Benicar, please contact AWKO law today at (888) 255-2956.
FDA Set to Evaluate Benicar Link to Adverse Side Effects
The popular hypertension drug Benicar has recently been linked to an increased risk of heart attack, stroke and sudden death. The U.S. Food and Drug Administration is currently reviewing data from two clinical trials in which patients taking Benicar had a higher rate of cardiovascular-related death than those taking a placebo.
Benicar falls under a category of drugs called angiotensin-receptor blockers (ARBs) and is frequently prescribed to patients who suffer from high blood pressure.
Benicar Side Effects
During the clinical trials, originally conducted to determine whether Benicar could slow the progression of kidney disease, surprising results showed an increased risk of heart failure, stroke and sudden death among type 2 diabetes patients who were taking Benicar when compared to patients taking a placebo.
Meanwhile, the FDA is asking patients not to discontinue the use of Benicar until further notice, stating that it believes the benefits of the drug outweigh its risks. However, the agency is urging both medical practitioners and individuals using Benicar to immediately report any adverse side effects.
Benicar is manufactured by Daiichi Sankyo. The pharmaceutical company, which has not yet responded to the latest data involving its product, could be facing a slew of personal injury and defective drug lawsuits if the FDA rules the findings viable.
If you or a loved one has suffered heart failure, stroke or sudden death while on Benicar, you may be eligible to receive compensation for your injuries, pain and suffering. The Pensacola personal injury attorneys of Aylstock, Witkin Kreis & Overholtz handle national litigation across the United States for victims injured by defective pharmaceuticals and medical devices. They have successfully represented and obtained substantial compensation for a number of patients who have been harmed by defective drugs. To learn more, please contact AWKO law today at (888) 255-2956.